Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
1.280
+0.342 (36.46%)
At close: Dec 20, 2024, 4:00 PM
1.240
-0.040 (-3.13%)
After-hours: Dec 20, 2024, 7:59 PM EST
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $56.27 million as of December 20, 2024. Its market cap has increased by 122.16% in one year.
Market Cap
56.27M
Enterprise Value
3.42M
1-Year Change
122.16%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $56.27M, a decrease of -86.81%. That is a compound annual growth rate of -47.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 56.27M | 271.62% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scilex Holding Company | 58.95M |
| Kronos Bio | 57.80M |
| Boundless Bio | 57.75M |
| LakeShore Biopharma | 56.48M |
| Serina Therapeutics | 56.35M |
| Repare Therapeutics | 56.11M |
| Modular Medical | 55.80M |
| CareCloud | 55.22M |